Mankind Pharma shareholders and shareholding pattern
NSE: MANKINDBSE: 543904Pharmaceuticals & BiotechnologyMid Cap
Last close ₹2,212.60down ₹63.00 (2.77%)BSE ₹2,217.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹2,275.60.
52-week range of traded prices to 23 Oct 2026
₹1,909.70Low, 23 Mar 2026₹2,642.00High, 29 Jul 2026
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹91,390 Cr119th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 44.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 5.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 13.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 12.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.38
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,79,10661.7% delivered
Who owns Mankind Pharma, filing by filing
Per cent of the company's shares. Every filing on record, from Jun 2023; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters72.62%
- Foreign institutions9.37%
- Indian institutions15.56%
- GovernmentsNone
- Individuals and others2.45%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Jun 2023Filed 17 Jul | Sep 2023Filed 12 Oct | Dec 2023Filed 8 Jan | Mar 2024Filed 4 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 14 Oct | Dec 2025Filed 13 Jan | Mar 2026Filed 20 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.50% | 76.50% | 76.50% | 74.88% | 74.87% | 74.87% | 72.71% | 72.70% | 72.68% | 72.67% | 72.66% | 72.66% | 72.63% | 72.62% | |
| Indian promoters | 76.50% | 76.50% | 76.50% | 74.88% | 74.87% | 74.87% | 72.71% | 72.70% | 72.68% | 72.67% | 72.66% | 72.66% | 72.63% | 72.62% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 23.50% | 23.50% | 23.50% | 25.12% | 25.13% | 25.13% | 27.29% | 27.30% | 27.32% | 27.33% | 27.34% | 27.34% | 27.37% | 27.38% |
| Shares in issue | 40,05,88,440 | 40,05,88,440 | 40,05,88,440 | 40,05,88,440 | 40,06,35,138 | 40,06,44,138 | 41,25,66,899 | 41,25,78,527 | 41,27,28,748 | 41,27,58,490 | 41,28,05,072 | 41,28,28,328 | 41,29,95,978 | 41,30,45,090 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 36,65,38,439 | 36,05,29,596 | 8,01,17,710 | 8,01,17,710 | 8,01,17,710 | 8,01,17,710 | 0 | 0 | – | – | – | – | – | – |
| Promoters' shares locked in | 30,64,50,146 | 30,64,50,146 | 8,01,17,710 | 8,01,17,710 | 8,01,17,710 | 8,01,17,710 | 0 | 0 | – | – | – | – | – | – |
A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Mankind Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Ramesh Juneja Family Trust (Held in the name of Ramesh Juneja, Managing Trustee), 20.18%. The filing names 79 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Ramesh Juneja Family Trust (Held in the name of Ramesh Juneja, Managing Trustee)Indian companies, trusts and others | 20.18% | 8,33,52,652 |
| Rajeev Juneja Family Trust (Held in the name of Rajeev Juneja, Managing Trustee)Indian companies, trusts and others | 19.35% | 7,99,30,520 |
| Prem Sheetal Family Trust (Held in the name of Arora Family Private Limited, Trustee)Indian companies, trusts and others | 14.95% | 6,17,55,635 |
| SHEETAL ARORAIndividuals and Hindu undivided families | 4.67% | 1,92,77,647 |
| PUJA JUNEJAIndividuals and Hindu undivided families | 2.79% | 1,15,33,906 |
| POONAM JUNEJAIndividuals and Hindu undivided families | 2.56% | 1,05,57,626 |
| ARJUN JUNEJAIndividuals and Hindu undivided families | 1.97% | 81,54,463 |
| RAMESH JUNEJAIndividuals and Hindu undivided families | 1.66% | 68,55,990 |
| RAJEEV JUNEJAIndividuals and Hindu undivided families | 1.57% | 65,00,021 |
| CHANAKYA JUNEJAIndividuals and Hindu undivided families | 0.94% | 38,96,788 |
| EKLAVYA JUNEJAIndividuals and Hindu undivided families | 0.94% | 38,96,788 |
| MISHKA ARORAIndividuals and Hindu undivided families | 0.72% | 29,55,692 |
No promoter shares are reported as pledged.
Largest public holders of Mankind Pharma, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Mankind Pharma
| Holder | Jun 2023Filed 17 Jul | Sep 2023Filed 12 Oct | Dec 2023Filed 8 Jan | Mar 2024Filed 4 Apr | Jun 2024Filed 12 Jul | Sep 2024Filed 18 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 14 Oct | Dec 2025Filed 13 Jan | Mar 2026Filed 20 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPS TRUST- A/C LIC PENSION FUND SCHEME - STATE GOVProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.65% |
| GOVERNMENT PENSION FUND GLOBALForeign portfolio investors, category I | – | – | – | – | – | 1.11% | 1.54% | 1.52% | 1.63% | 1.68% | 1.65% | 1.53% | 1.29% | 1.06% |
| NPS TRUST - A/C SBI PENSION FUND SCHEME - CORPORATProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | 2.77% | – |
| NPS TRUST- A/C SBI PENSION FUND PVT LTD APY FUND SProvident and pension funds | – | – | – | – | – | – | – | 1.02% | – | – | – | 2.77% | – | – |
| NPS TRUST A/C - LIC PENSION FUND - UPS - CG SCHEMEProvident and pension funds | – | – | – | – | – | – | – | – | – | – | 2.61% | – | – | – |
| NPS TRUST- A/C ICICI PRUDENTIAL PENSION FUND SCHEMProvident and pension funds | – | – | – | – | – | – | – | – | – | 2.08% | – | – | – | – |
| SBI LIFE INSURANCE CO. LTDInsurance companies | – | – | – | – | – | – | – | 1.05% | 1.07% | 1.19% | – | – | – | – |
| NPS TRUST A/C - SBI PENSION FUND - UPS - CG SCHEMEProvident and pension funds | – | – | – | – | – | – | – | – | 1.59% | – | – | – | – | – |
| TATA AIA LIFE INSURANCE COMPANY LIMITED A/C GROUPInsurance companies | – | – | – | – | – | 1.08% | – | – | – | – | – | – | – | – |
| HEMA CIPEF (I) LIMITEDCompanies | 3.63% | 3.63% | 2.22% | 2.22% | 1.62% | – | – | – | – | – | – | – | – | – |
| BEIGE LIMITEDCompanies | 7.46% | 7.46% | 2.99% | – | – | – | – | – | – | – | – | – | – | – |
| CAIRNHILL CIPEF LIMITEDCompanies | 1.74% | 1.74% | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.